Searching in BFARM · Search everything
3 changes Priority review, last 7 days
Melphalan AqVida: Risk of Overdose Due to Higher Concentration
The German Federal Institute for Drugs and Medical Devices (BfArM) issued a communication regarding Melphalan AqVida RTD 90 mg/ml, a new formulation with an 18-fold higher concentration than existing melphalan products. This increased concentration poses a potential risk of overdose for patients.
Tegretal Suspension Use Restricted in Newborns
The German Federal Institute for Drugs and Medical Devices (BfArM) has issued a direct healthcare professional communication restricting the use of Tegretal Suspension (carbamazepine) in newborns due to high propylene glycol content. This restriction is to prevent serious side effects in infants.
Digimerck Tablets Quality Defect: Degradation Products May Exceed Limit
The German Federal Institute for Drugs and Medical Devices (BfArM) issued a Direct Healthcare Professional Communication regarding Digimerck 0.07 mg tablets. A quality defect has been identified where degradation products may slightly exceed the specification limit by the end of the product's shelf life. Distribution was discontinued in 2022.
Get alerts for ""
We'll email you when new changes match this search.
Free. Unsubscribe anytime.